Can-Fite BioPharma (CANF) Soars on Psoriasis Trial Data
Monday, March 31, 2025 5:20:14 PM
Post# of 88
Post# of 88
Posted On: 04/27/2015 5:27:36 PM
Shares of Celladon Corporation (CLDN) decreased in value dramatically and touched an all-time low Monday after the company said that its Phase 2b CUPID2 trial evaluating the cardiovascular gene therapy agent MYDICAR(R) versus placebo did not meet its primary and secondary endpoints.
Brokerage firm ROTH Capital has downgraded CLDN stock from Buy to Neutral with a price target of $2.00 per share
CLDN is a clinical-stage biotechnology company applying its leadership position in the field of cardiovascular gene therapy to develop novel therapies for diseases with high unmet medical needs.
More about Celladon Corporation (CLDN) at www.celladon.com
**
The price of the stock of Can-Fite BioPharma Ltd. (CANF) soared more than 50% in early trading Monday as the company announced favorable data from further analysis of its Phase II/III study designed to test the efficacy of CF101, an orally bioavailable drug, in patients with moderate-to-severe plaque psoriasis.
Psoriasis is a common skin condition manifested by scaly plaques on the skin and in the severe form has a major effect on the physical and emotional well-being of the patients.
According to CANF, the new data shows that CF101 could serve as a first-line therapy for moderate-severe psoriasis based on the higher efficacy in patients who were previously not treated with systemic therapy.
CANF is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, inflammatory disease and sexual dysfunction.
More about Can-Fite BioPharma Ltd. (CANF) at www.can-fite.com
**
Crown Equity Holdings Inc. (CRWE) provides marketing solutions that boost customer awareness and merchant visibility on the Internet. The company is currently developing its CRWE Network ( www.CRWE-PR.com ), a growing network of community targeted sites.
It has recently included the City of Loma Linda, CA ( www.lomalinda.crwe-pr.com ) into the CRWE Network.
Loma Linda is located in San Bernardino County, California. It is well known for its national center of health and wellness research for all ages.
The City of Loma Linda had an estimated population in 2013 (U.S. Census Bureau) of 23,704, and represents an important marketplace for the CRWE Network, which business model is based on selling advertising to businesses targeting both locally and nationally
The CRWE Network has reached the 1487th community website in the U.S. and includes coverage in the states of California, Mississippi, Michigan, Florida, Nevada and New York, as well as across 10 provinces in Canada.
The CRWE-PR Business Directory portal ( www.BusinessDirectory.crwe-pr.com ) is the company’s business directory service that is available to all United States and Canada business in the public and private sector. It allows business owners and executives the ability to claim their business listings and provide more detailed information for their potential customers who visit the CRWE Network everyday.
More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com
**
Disclaimer: CRWE-PR Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at CRWE-PR Finance www.finance.crwe-pr.com/disclaimer
Brokerage firm ROTH Capital has downgraded CLDN stock from Buy to Neutral with a price target of $2.00 per share
CLDN is a clinical-stage biotechnology company applying its leadership position in the field of cardiovascular gene therapy to develop novel therapies for diseases with high unmet medical needs.
More about Celladon Corporation (CLDN) at www.celladon.com
**
The price of the stock of Can-Fite BioPharma Ltd. (CANF) soared more than 50% in early trading Monday as the company announced favorable data from further analysis of its Phase II/III study designed to test the efficacy of CF101, an orally bioavailable drug, in patients with moderate-to-severe plaque psoriasis.
Psoriasis is a common skin condition manifested by scaly plaques on the skin and in the severe form has a major effect on the physical and emotional well-being of the patients.
According to CANF, the new data shows that CF101 could serve as a first-line therapy for moderate-severe psoriasis based on the higher efficacy in patients who were previously not treated with systemic therapy.
CANF is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, inflammatory disease and sexual dysfunction.
More about Can-Fite BioPharma Ltd. (CANF) at www.can-fite.com
**
Crown Equity Holdings Inc. (CRWE) provides marketing solutions that boost customer awareness and merchant visibility on the Internet. The company is currently developing its CRWE Network ( www.CRWE-PR.com ), a growing network of community targeted sites.
It has recently included the City of Loma Linda, CA ( www.lomalinda.crwe-pr.com ) into the CRWE Network.
Loma Linda is located in San Bernardino County, California. It is well known for its national center of health and wellness research for all ages.
The City of Loma Linda had an estimated population in 2013 (U.S. Census Bureau) of 23,704, and represents an important marketplace for the CRWE Network, which business model is based on selling advertising to businesses targeting both locally and nationally
The CRWE Network has reached the 1487th community website in the U.S. and includes coverage in the states of California, Mississippi, Michigan, Florida, Nevada and New York, as well as across 10 provinces in Canada.
The CRWE-PR Business Directory portal ( www.BusinessDirectory.crwe-pr.com ) is the company’s business directory service that is available to all United States and Canada business in the public and private sector. It allows business owners and executives the ability to claim their business listings and provide more detailed information for their potential customers who visit the CRWE Network everyday.
More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com
**
Disclaimer: CRWE-PR Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at CRWE-PR Finance www.finance.crwe-pr.com/disclaimer
(0)
(0)Can-Fite Biopharma Ltd. (CANF) Stock Research Links
Scroll down for more posts ▼